Topics

Nventa Biopharmaceuticals Corporation Company Profile

04:30 EST 29th February 2020 | BioPortfolio

Nventa Biopharmaceuticals Corporation (TSX:NVN) is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). Our lead therapeutic candidate is HspE7, a novel therapeutic vaccine designed for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. An estimated 80% of sexually active men and women are infected by genital HPV at some point in their lives. Approximately 5.5 million new sexually transmitted HPV infections are reported in the U.S. each year. At least 20 million people in the U.S. are already infected. HPV infection can result in diseases including internal and external genital warts and precancerous conditions, such as cervical and anal dysplasia. Precancerous HPV-related conditions can progress into life-threatening diseases, including cervical, anal, and head and neck cancers.

Location

6055 Lusk Boulevard
San Diego
California
92121
United States of America

Contact

Phone: (858) 202-4900
Fax: (858) 450-6849
Email: dquarry@nventacorp.com


News Articles [191 Associated News Articles listed on BioPortfolio]

Lundbeck to buy Alder BioPharmaceuticals for £1.56bn

Alder BioPharmaceuticals is involved in the discovery, development and commercialisation of novel therapeutic antibodies. As per terms of the deal, Lundbeck will begin a tender offer for all The post...

Lundbeck signs $1.95bn deal to buy Alder BioPharmaceuticals

Danish pharmaceutical company Lundbeck has signed a definitive agreement to acquire all outstanding shares of US-based Alder BioPharmaceuticals for a...Read More... The post Lundbeck signs $1.95bn dea...

Turbo-charging pharmaceutical biotechnology simulations

Demand for biopharmaceuticals is strong: biopharmaceutical active ingredients – in other words, genetically engineered drugs – accounted for seven of the ten top-selling medications in the world ...

Lundbeck to pay $1.9B for Alder BioPharmaceuticals acquisition

Lundbeck of Denmark will acquire Alder BioPharmaceuticals in a $1.95 billion deal that will improve the former's biologics ca -More- 

Seven and Eight Biopharmaceuticals to combine BDB001 with Roche’s Tecentriq

Seven and Eight Biopharmaceuticals Inc. and Roche agreed to trial a combination of the former’s BDB001 and latter’s Tecentriq (atezolizumab) in solid tumors.

Innovate Biopharmaceuticals, Inc: Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts for the 2020 Digestive Disease Week (DDW) Conference

Highlighting Larazotide's Effect across the Gut-Vascular Barrier - a Fundamental Disease Mechanism in a Variety of Autoimmune and Inflammatory Diseases RALEIGH, NC / ACCESSWIRE / February 19, 2020 ...

Apotex And Intas Biopharmaceuticals Extend Their Collaborative Development Of Biosimilars To Include Pegfilgrastim

Apotex Inc. of Canada and Intas Biopharmaceuticals Limited (IBPL) of India have extended their business agreement to develop a biosimilar version of pegfilgrastim, a protein that is used to treat neut...

Innovate Biopharmaceuticals, Inc: Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company Focused on Specialty, Rare and Orphan Diseases

Deep Clinical-Stage Pipeline Combined With World-Class Leadership Team OrbiMed Advisors LLC to Lead a Concurrent Capital Raise 9 Meters Biopharma, Inc. Will Be the New Name of the Combined NASDAQ-L...

PubMed Articles [35 Associated PubMed Articles listed on BioPortfolio]

Development of reporter gene assays to determine the bioactivity of biopharmaceuticals.

Complex structure and structure-function relationship of biopharmaceuticals require extensive analytical characterization and appropriate quality control of the products. Despite rapid development of ...

Detection and quantification of leached ethylene glycol in biopharmaceuticals by RP-UHPLC.

Biopharmaceuticals are in direct contact with different plastic materials, which can contribute to process-related impurities. Polyethylene terephthalate glycol (PETG) is used for storage and transpor...

Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals.

Charge heterogeneity profiling is important for the quality control (QC) of biopharmaceuticals. Because of the increasing complexity of these therapeutic entities 1, the development of alternative ana...

Correction to: Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta‑Analysis.

The authors unintentionally included in the meta-analysis both the initial abstract and the final paper of the study by Puertolas et al. [45, 48]. In order to remove this duplication, the following co...

An Industry Perspective on Forced Degradation Studies of Biopharmaceuticals: Survey Outcome and Recommendations.

The BioPhorum Development Group (BPDG) is an industry-wide consortium enabling networking and sharing of common practices for the development of biopharmaceuticals. Forced degradation studies (FDS) ar...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Conversion to Dysport in Cervical Dystonia Patients

The first line of therapy for cervical dystonia patients is botulinum toxin injections, however injection parameter determination and optimization are challenging for physicians to do. In ...

Companies [384 Associated Companies listed on BioPortfolio]

Nventa Biopharmaceuticals Corporation

Nventa Biopharmaceuticals Corporation (TSX:NVN) is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). Our le...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...

More Information about "Nventa Biopharmaceuticals Corporation" on BioPortfolio

We have published hundreds of Nventa Biopharmaceuticals Corporation news stories on BioPortfolio along with dozens of Nventa Biopharmaceuticals Corporation Clinical Trials and PubMed Articles about Nventa Biopharmaceuticals Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nventa Biopharmaceuticals Corporation Companies in our database. You can also find out about relevant Nventa Biopharmaceuticals Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cervical Cancer
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated using surgery (including local excision) in early stages...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record